Vol. 45 No. 1 (2023): Experimental Oncology

Reviews

  • NEUROENDOCRINE PEPTIDES IN THE PATHOGENESIS OF COLORECTAL CARCINOMA

    A. Ramírez-Perdomo, G. Márquez-Barrios, L.D. Gutiérrez, R. Parra-Medina
    3-16
    DOI: https://doi.org/10.15407/exp-oncology.2023.01.003

Original contributions

  • PATTERN OF MMP2 AND MMP9 EXPRESSION DEPENDS ON BREAST CANCER PATIENTS’ AGE

    N. Lukianova, O. Mushii, T. Borikun, T. Zadvornyi, V. Bazas, M. Krotevych, L. Sivak, S. Lyalkin, О. Martynyuk, S. Hrybach, V. Chekhun
    17-27
    DOI: https://doi.org/10.15407/exp-oncology.2023.01.017
  • ABERRANT EXPRESSION OF COL14A1, CELRS3, and CTHRC1 IN BREAST CANCER СELLS

    Shreshtha Malvia, Chintamani Chintamani, Ramesh Sarin, Uma S Dubey, Sunita Saxena, Sarangadhara Appala Raju Bagadi
    28-43
    DOI: https://doi.org/10.15407/exp-oncology.2023.01.028
  • EXPRESSION OF PROGRAMMED CELL DEATH RECEPTOR IN ENDOMETRIAL CANCER PATIENTS WITH METABOLIC DISORDERS

    O.V. Kuzmenko, P.P. Sorochan, I.S. Gromakova, V.G. Shevtsov, M.O. Ivanenko, M.V. Polozova
    44-50
    DOI: https://doi.org/10.15407/exp-oncology.2023.01.044
  • ROLE OF STROMAL MICROENVIRONMENT IN THE FORMATION OF INVASIVE, ANGIOGENIC, AND METASTATIC POTENTIAL OF ENDOMETRIOID CARCINOMA OF ENDOMETRIUM

    N.P. Iurchenko, I.P. Nesina, N.М. Glushchenko, L.G. Buchynska
    51-61
    DOI: https://doi.org/10.15407/exp-oncology.2023.01.051
  • NEW DATA ON HISTOGENESIS AND HISTOLOGICAL STRUCTURE OF LUNG CANCER

    L. Bolgova, A. Shypko, T. Tuganova, O. Alekseenko, I. Smolanka, A. Ponomarenko, N. Bilko
    62-69
    DOI: https://doi.org/10.15407/exp-oncology.2023.01.062
  • FAMILIAL NON-MEDULLARY THYROID CARCINOMA

    B.B. Guda, I.I. Komisarenko, M.V. Ostafiichuk, M.D. Tronko
    70-78
    DOI: https://doi.org/10.15407/exp-oncology.2023.01.070
  • EXPRESSION OF HEPATOCYTE GROWTH FACTOR AND C-MET RECEPTOR IN STROMAL FIBROBLASTS AND TUMOR CELLS OF ENDOMETRIAL CARCINOMA

    L.G. Buchynska, O.V. Brieieva, S.V. Nespriadko
    79-87
    DOI: https://doi.org/10.15407/exp-oncology.2023.01.079
  • CANCER-ASSOCIATED ADIPOCYTES AND PROGNOSTIC VALUE OF PREOPERATIVE NEUTROPHIL-LYMPHOCYTE RATIO IN GASTRIC CANCER

    L. Bubnovskaya, I. Ganusevich, S. Merentsev, D. Osinsky
    88-98
    DOI: https://doi.org/10.15407/exp-oncology.2023.01.088
  • DIAGNOSTICS OF LYMPHOGENIC METASTASIS IN PATIENTS WITH RECTAL CANCER BY COMBINING MRI WITH BLOOD CEA ASSESSMENT

    S.V. Maliborska, V.V. Holotiuk, Y.D. Partykevich, I.S. Holotiuk
    99-106
    DOI: https://doi.org/10.15407/exp-oncology.2023.01.099
  • SKELETAL MUSCLE SENSITIVITY TO WASTING INDUCED BY UROTHELIAL CARCINOMA

    M. Esteves, M. Duarte, P.A. Oliveira, R.M. Gil da Costa, M.P. Monteiro, J.A. Duarte
    107-119
    DOI: https://doi.org/10.15407/exp-oncology.2023.01.107

Short communications

Case report

Methods and techniques

  • COMPARISON OF 2D AND 3D PRIMARY CELL CULTURES OBTAINED FROM EXPLANT OF HIGH-GRADE UROTHELIAL BLADDER CANCER

    L.V. Garmanchuk, P.G. Yakovlev, G.V. Ostrovska, Yu.A. Stupak, O.V. Skachkova, O.I. Gorbach, Yu.V. Stepanov
    130-136
    DOI: https://doi.org/10.15407/exp-oncology.2023.01.130